259 related articles for article (PubMed ID: 22770914)
21. Pharmacists' knowledge of issues in pharmacotherapy of epilepsy using antiepileptic drugs: A cross-sectional study in Palestinian pharmacy practice.
Shawahna R; Atrash A; Jebril A; Khalaf A; Shaheen E; Tahboosh H
Epilepsy Behav; 2017 Feb; 67():39-44. PubMed ID: 28088050
[TBL] [Abstract][Full Text] [Related]
22. Explanatory factors of adherence to community-based management of epilepsy in Lao PDR.
Bounlu M; Auditeau E; Vorachit S; Chivorakoun P; Souvong V; Sengxeu N; Preux PM; Boumediene F
Epilepsy Behav; 2018 Nov; 88():74-80. PubMed ID: 30241057
[TBL] [Abstract][Full Text] [Related]
23. Impact of epilepsy and antiepileptic drugs on health and quality of life in Indian children.
Nagabushana D; S PK; Agadi JB
Epilepsy Behav; 2019 Apr; 93():43-48. PubMed ID: 30831401
[TBL] [Abstract][Full Text] [Related]
24. Suicidality in people taking antiepileptic drugs: What is the evidence?
Bell GS; Mula M; Sander JW
CNS Drugs; 2009; 23(4):281-92. PubMed ID: 19374458
[TBL] [Abstract][Full Text] [Related]
25. An evaluation of factors affecting adherence to antiepileptic drugs in patients with epilepsy: a cross-sectional study.
Gurumurthy R; Chanda K; Sarma G
Singapore Med J; 2017 Feb; 58(2):98-102. PubMed ID: 26805666
[TBL] [Abstract][Full Text] [Related]
26. Epilepsy care cascade, treatment gap and its determinants in rural South Africa.
Wagner RG; Kabudula CW; Forsgren L; Ibinda F; Lindholm L; Kahn K; Tollman S; Newton CR
Seizure; 2020 Aug; 80():175-180. PubMed ID: 32593141
[TBL] [Abstract][Full Text] [Related]
27. Antiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy.
Getnet A; Woldeyohannes SM; Bekana L; Mekonen T; Fekadu W; Menberu M; Yimer S; Assaye A; Belete A; Belete H
Behav Neurol; 2016; 2016():3189108. PubMed ID: 28053370
[No Abstract] [Full Text] [Related]
28. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project.
Sirven JI; Shafer PO; Kalilani L; Wild I; Fishman J; Owens S
Epilepsy Behav; 2018 Mar; 80():98-103. PubMed ID: 29414565
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 containment and its unrestrained impact on epilepsy management in resource-limited areas of Pakistan.
Saleem T; Sheikh N; Abbasi MH; Javed I; Khawar MB
Epilepsy Behav; 2020 Nov; 112():107476. PubMed ID: 33181895
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
[TBL] [Abstract][Full Text] [Related]
31. The effects of medication education and behavioral intervention on Chinese patients with epilepsy.
Tang F; Zhu G; Jiao Z; Ma C; Chen N; Wang B
Epilepsy Behav; 2014 Aug; 37():157-64. PubMed ID: 25022824
[TBL] [Abstract][Full Text] [Related]
32. Impact of complementary and alternative medicines on antiepileptic medication adherence among epilepsy patients.
Farrukh MJ; Makmor-Bakry M; Hatah E; Jan TH
BMC Complement Med Ther; 2021 Feb; 21(1):50. PubMed ID: 33541336
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies.
Ngugi AK; Bottomley C; Kleinschmidt I; Wagner RG; Kakooza-Mwesige A; Ae-Ngibise K; Owusu-Agyei S; Masanja H; Kamuyu G; Odhiambo R; Chengo E; Sander JW; Newton CR;
Lancet Neurol; 2013 Mar; 12(3):253-63. PubMed ID: 23375964
[TBL] [Abstract][Full Text] [Related]
34. Antiepileptic Treatments in Developing Countries.
Jost J; Millogo A; Preux PM
Curr Pharm Des; 2017; 23(37):5740-5748. PubMed ID: 28799515
[TBL] [Abstract][Full Text] [Related]
35. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
36. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.
Chen Z; Brodie MJ; Liew D; Kwan P
JAMA Neurol; 2018 Mar; 75(3):279-286. PubMed ID: 29279892
[TBL] [Abstract][Full Text] [Related]
37. Antiepileptic drugs for seizure control in people with neurocysticercosis.
Sharma M; Singh T; Mathew A
Cochrane Database Syst Rev; 2015 Oct; (10):CD009027. PubMed ID: 26455722
[TBL] [Abstract][Full Text] [Related]
38. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
Groth A; Wilke T; Borghs S; Gille P; Joeres L
Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
[No Abstract] [Full Text] [Related]
39. Comparing characteristics of epilepsy treatment providers on the Kenyan coast: implications for treatment-seeking and intervention.
Kendall-Taylor NH; Kathomi C; Rimba K; Newton CR
Rural Remote Health; 2009; 9(4):1253. PubMed ID: 19827905
[TBL] [Abstract][Full Text] [Related]
40. Seizure-related vehicular crashes and falls with injuries for people with epilepsy (PWE) in northeastern Thailand.
Saengsuwan J; Laohasiriwong W; Boonyaleepan S; Sawanyawisuth K; Tiamkao S; Talkul A;
Epilepsy Behav; 2014 Mar; 32():49-54. PubMed ID: 24480154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
